American International Group’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,524
| Closed | -$321K | – | 1359 |
|
|
2024
Q1 | $321K | Sell |
8,524
-72
| -0.8% | -$2.71K | ﹤0.01% | 1877 |
|
|
2023
Q4 | $92.2K | Sell |
8,596
-35
| -0.4% | -$376 | ﹤0.01% | 2607 |
|
|
2023
Q3 | $87K | Buy |
8,631
+307
| +4% | +$3.1K | ﹤0.01% | 2579 |
|
|
2023
Q2 | $98.8K | Buy |
8,324
+42
| +0.5% | +$499 | ﹤0.01% | 2581 |
|
|
2023
Q1 | $100K | Buy |
8,282
+164
| +2% | +$1.98K | ﹤0.01% | 2451 |
|
|
2022
Q4 | $107K | Sell |
8,118
-29
| -0.4% | -$382 | ﹤0.01% | 2472 |
|
|
2022
Q3 | $110K | Buy |
8,147
+115
| +1% | +$1.55K | ﹤0.01% | 2496 |
|
|
2022
Q2 | $98K | Sell |
8,032
-781
| -9% | -$9.53K | ﹤0.01% | 2610 |
|
|
2022
Q1 | $126K | Buy |
8,813
+1,782
| +25% | +$25.5K | ﹤0.01% | 2493 |
|
|
2021
Q4 | $139K | Sell |
7,031
-211
| -3% | -$4.17K | ﹤0.01% | 2568 |
|
|
2021
Q3 | $157K | Buy |
+7,242
| New | +$157K | ﹤0.01% | 2576 |
|